Launch of Evrenzo ® (roxadustat) Tablets in Japan for the Treatment of Renal Anemia in Patients on Dialysis
The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia - ScienceDirect
Roxadustat | Drug Information, Uses, Side Effects, Chemistry | PharmaCompass.com
ROXADUSTAT-TAB ZAF_2021-Patient South Africa en N/A
Eskayef Pharmaceuticals Ltd. | Brand | Oroxat
Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout | Business Wire
Adcom says 'not yet,' but opens small window for roxadustat | 2021-07-15 | BioWorld
Visto bueno para roxadustat como tratamiento para adultos con anemia sintomática asociada a enfermedad renal crónica - Farmacosalud
Eskayef Pharmaceuticals Ltd. | Brand | Oroxat
Roxadustat, ASP 1517, FG 4592 | New Drug Approvals
File:Roxadustat.svg - Wikipedia
CAS No : 808118-40-3 | Product Name : Roxadustat - API | Chemical Name : Roxadustat | Pharmaffiliates
Comprar Evrenzo (roxadustat) en línea - Precio y costes | Everyone.org
AstraZeneca's partner FibroGen gets Chinese approval for CKD treatment roxadustat
Eskayef Pharmaceuticals Ltd. | Brand | Oroxat
Renesis (Roxadustat) - Beacon Pharmaceuticals PLC
Astellas' EVRENZO▽™ (roxadustat) to be reimbursed under the High Tech Drugs Scheme in Ireland For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease (CKD) - Irish Pharmacy News